Solid Tumors Harboring a TP53 Y220C Mutation
1 clinical trials · Condition
◉ Watch Solid Tumors Harboring a TP53 Y220C Mutation
| Record | Firm | Date |
|---|---|---|
| A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C Mutation (NCT06908434) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2025-06-10 |
Track Solid Tumors Harboring a TP53 Y220C Mutation automatically
Every clearance here is in the API, with alerts when new ones post.